Multicenter Clinical Study of Anti-VEGF Treatment on High Risk Diabetic Retinopathy (DR)

NCT03452657 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

118

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Retinopathy
Ranibizumab

Interventions

DRUG: Ranibizumab
PROCEDURE: No drug

Sponsor

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]